Your account is not claimed yet. You can sign up with ORCID to claim your account.

Emad A Rakha (Emad Rakha)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 55

Top Venues

Histopathology

Journal of clinical pathology

Breast cancer research and treatment

British journal of cancer

University of Nottingham

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Nottingham May 1o 2011

United Kingdom

Professor :: Pathology

Publications

Asmaa Ibrahim, Michael S Toss, Nehal M Atallah, Mansour Al Saleem, Andrew R Green, Emad A Rakha
Combined proliferation and apoptosis index provides better risk stratification in breast cancer. Histopathology (2023)
Rabab Alkhayyat, Areeg Abbas, Cecily M Quinn, Emad A Rakha
Tumour 63 protein (p63) in breast pathology: biology, immunohistochemistry, diagnostic applications, and pitfalls. Histopathology (2023)
Asmaa Ibrahim, Michael S Toss, Nehal M Atallah, Mansour Al Saleem, Andrew R Green, Emad A Rakha
Combined proliferation and apoptosis index provides better risk stratification in breast cancer. Histopathology (2023)
Ayat Gamal Lashen, Michael S Toss, Louisa Wootton, Andrew R Green, Nigel Patrick Mongan, Madhusudhan Srinivasan, Emad A Rakha
Characteristics and prognostic significance of polo-like kinase-1 (PLK1) expression in breast cancer. Histopathology (2023)
Emad A Rakha, Luqman Adedotun Adebayo, Areeg Abbas, Zsolt Hodi, Andrew H S Lee, Ian O Ellis
Second opinion (external specialist referral) practice of breast pathology: the Nottingham experience. Histopathology (2023)
Adel Alblihy, Reem Ali, Mashael Algethami, Alison A Ritchie, Ahmed Shoqafi, Shatha Alqahtani, Katia A Mesquita, Michael S Toss, Paloma Ordóñez-Morán, Jennie N Jeyapalan, Lodewijk V Dekker, Martina Salerno, Edgar Hartsuiker, Anna M Grabowska, Emad A Rakha, Nigel P Mongan, Srinivasan Madhusudan
Selective Killing of BRCA2-Deficient Ovarian Cancer Cells via MRE11 Blockade. International journal of molecular sciences 24 (13) (2023)
Ayat Gamal Lashen, Michael S Toss, Wakkas Fadhil, Georgette Oni, Srinivasan Madhusudan, Emad A Rakha
Evaluation oncotype DX ® 21-gene recurrence score and clinicopathological parameters: a single institutional experience. Histopathology (2023)
Andrew H S Lee, Zsolt Hodi, Areeg Abbas, Peter Wencyk, Ian O Ellis, Emad A Rakha
Should a borderline negative HER2 result in a core biopsy of invasive carcinoma of the breast have HER2 assessment repeated in the excision specimen? Journal of clinical pathology (2023)
Ayat Gamal Lashen, Michael S Toss, Suzan Fathy Ghannam, Shorouk Makhlouf, Andrew Green, Nigel P Mongan, Emad A Rakha
Expression, assessment and significance of Ki67 expression in breast cancer: an update. Journal of clinical pathology (2023)
Ayat Gamal Lashen, Michael S Toss, Wakkas Fadhil, Georgette Oni, Srinivasan Madhusudan, Emad A Rakha
Evaluation oncotype DX ® 21-gene recurrence score and clinicopathological parameters: a single institutional experience. Histopathology 82 (5) (2023)
Ayat Gamal Lashen, Michael S Toss, Wakkas Fadhil, Georgette Oni, Srinivasan Madhusudan, Emad A Rakha
Evaluation Oncotype DX® 21-Gene Recurrence Score and Clinicopathological Parameters: A single institutional experience. Histopathology (2023)
Andrew H S Lee, Michael S Toss, Jonathan J James, Zsolt Hodi, Ian O Ellis, Emad A Rakha
Preoperative diagnosis of ductal carcinoma in situ of the breast over a 24-year period. Histopathology (2023)
Ayat Gamal Lashen, Michael S Toss, Wakkas Fadhil, Georgette Oni, Srinivasan Madhusudan, Emad A Rakha
Evaluation oncotype DX ® 21-gene recurrence score and clinicopathological parameters: a single institutional experience. Histopathology 82 (5) (2023)
Sho Shiino, Cecily Quinn, Graham Ball, Binafsha M Syed, Sasagu Kurozumi, Hitoshi Tsuda, Emad A Rakha
Prognostic significance of microinvasion with ductal carcinoma in situ of the breast: a meta-analysis. Breast cancer research and treatment (2022)
Ayat Gamal Lashen, Michael S Toss, Andrew R Green, Nigel Patrick Mongan, Emad A Rakha
Ki67 assessment in invasive luminal breast cancer: a comparative study between different scoring methods. Histopathology 81 (6) (2022)
Emad A Rakha, Puay Hoon Tan, Cecily Quinn, Elena Provenzano, Abeer M Shaaban, Rahul Deb, Grace Callagy, Jane Starczynski, Andrew H S Lee, Ian O Ellis, Sarah E Pinder
UK recommendations for HER2 assessment in breast cancer: an update. Journal of clinical pathology (2022)
Cecily M Quinn, Aoife Maguire, Emad A Rakha
Pitfalls in breast pathology. Histopathology 82 (1) (2022)
Emad A Rakha, Gary M K Tse, Cecily M Quinn
An update on the pathological classification of breast cancer. Histopathology 82 (1) (2022)
Emad A Rakha, Gary M K Tse, Cecily M Quinn
An update on the pathological classification of breast cancer. Histopathology 82 (1) (2022)
Ian O Ellis, Emad A Rakha, Gary M K Tse, Puay Hoon Tan
An international unified approach to reporting and grading invasive breast cancer. An overview of the International Collaboration on Cancer Reporting (ICCR) initiative. Histopathology 82 (1) (2022)
Emad A Rakha, Gary M K Tse, Cecily M Quinn
An update on the pathological classification of breast cancer. Histopathology 82 (1) (2022)
Ian O Ellis, Emad A Rakha, Gary M K Tse, Puay Hoon Tan
An international unified approach to reporting and grading invasive breast cancer. An overview of the International Collaboration on Cancer Reporting (ICCR) initiative. Histopathology 82 (1) (2022)
Ayaka Katayama, Jane Starczynski, Michael S Toss, Abeer M Shaaban, Elena Provenzano, Cecily M Quinn, Grace Callagy, Colin A Purdie, Rebecca Millican-Slater, David Purnell, Leena Chagla, Tetsunari Oyama, Sarah E Pinder, Steve Chan, Ian Ellis, Andrew H S Lee, Emad A Rakha
The frequency and clinical significance of centromere enumeration probe 17 alterations in human epidermal growth factor receptor 2 immunohistochemistry-equivocal invasive breast cancer. Histopathology 81 (4) (2022)
Nehal M Atallah, Michael S Toss, Andrew R Green, Nigel P Mongan, Graham Ball, Emad A Rakha
Refining the definition of HER2-low class in invasive breast cancer. Histopathology 81 (6) (2022)
Gary M K Tse, Puay Hoon Tan, Emad A Rakha
Annual Review Issue: Breast Pathology. Histopathology 82 (1) (2022)
Anastasia Constantinidou, Yiola Marcou, Michael S Toss, Timothy Simmons, Ryan Bernhisel, Elisha Hughes, Braden Probst, Stephanie Meek, Eleni Kakouri, Georgios Georgiou, Ioanna Zouvani, Gabriella Savvidou, Vanessa Kuhl, Jennifer Doedt, Susanne Wagner, Alexander Gutin, Thomas P Slavin, Jerry S Lanchbury, Ralf Kronenwett, Ian O Ellis, Emad A Rakha
Clinical Validation of EndoPredict in Pre-Menopausal Women with ER-Positive, HER2-Negative Primary Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (20) (2022)
Asmaa Ibrahim, Michael S Toss, Shorouk Makhlouf, Islam M Miligy, Fayyaz Ul Amir Afsar Minhas, Emad A Rakha
Improving mitotic cell counting accuracy and efficiency using phosphohistone-H3 (PHH3) antibody counterstained with haematoxylin and eosin as part of breast cancer grading. Histopathology (2022)
Gary M K Tse, Puay Hoon Tan, Emad A Rakha
Annual Review Issue: Breast Pathology. Histopathology 82 (1) (2022)
Emad A Rakha, Puay Hoon Tan, Cecily Quinn, Elena Provenzano, Abeer M Shaaban, Rahul Deb, Grace Callagy, Jane Starczynski, Andrew H S Lee, Ian O Ellis, Sarah E Pinder
UK recommendations for HER2 assessment in breast cancer: an update. Journal of clinical pathology 76 (4) (2022)
Ian O Ellis, Emad A Rakha, Gary M K Tse, Puay Hoon Tan
An international unified approach to reporting and grading invasive breast cancer. An overview of the International Collaboration on Cancer Reporting (ICCR) initiative. Histopathology 82 (1) (2022)
Emad A Rakha, Puay Hoon Tan, Cecily Quinn, Elena Provenzano, Abeer M Shaaban, Rahul Deb, Grace Callagy, Jane Starczynski, Andrew H S Lee, Ian O Ellis, Sarah E Pinder
UK recommendations for HER2 assessment in breast cancer: an update. Journal of clinical pathology 76 (4) (2022)
Stephen B Fox, Fluer Webster, Chih-Jung Chen, Boon Chua, Laura Collins, Maaria-Pia Foschini, G Bruce Mann, Ewan Millar, Sarah E Pinder, Emad A Rakha, Abeer Shaaban, Benjamin Yongcheng Tan, Gary M K Tse, Peter Watson, Puay Hoon Tan
Dataset for pathology reporting of ductal carcinoma in situ, variants of lobular carcinoma in situ and low-grade lesions: recommendations from the International Collaboration on Cancer Reporting (ICCR). Histopathology 81 (4) (2022)
Cecily M Quinn, Aoife Maguire, Emad A Rakha
Pitfalls in breast pathology. Histopathology 82 (1) (2022)
Emad A Rakha, Puay Hoon Tan, Cecily Quinn, Elena Provenzano, Abeer M Shaaban, Rahul Deb, Grace Callagy, Jane Starczynski, Andrew H S Lee, Ian O Ellis, Sarah E Pinder
UK recommendations for HER2 assessment in breast cancer: an update. Journal of clinical pathology 76 (4) (2022)
Emad A Rakha, Puay Hoon Tan
Head to head: do neuroendocrine tumours in the breast truly exist? Histopathology 81 (1) (2022)
Gary M K Tse, Puay Hoon Tan, Emad A Rakha
Annual Review Issue: Breast Pathology. Histopathology 82 (1) (2022)
Emad A Rakha, Raluca Mihai, Areeg Abbas, Rachel Bennett, Michela Campora, Philippa Morena, Michael Toss, Ian Ellis
Diagnostic concordance of phyllodes tumour of the breast. Histopathology 79 (4) (2021)
Raluca Mihai, Grace Callagy, Omar L Qassid, Mark O Loughlin, Lena Al-Hilfi, Areeg Abbas, Michela Campora, Zsolt Hodi, Ian Ellis, Andrew H S Lee, Emad A Rakha
Correlations of morphological features and surgical management with clinical outcome in a multicentre study of 241 phyllodes tumours of the breast. Histopathology 78 (6) (2021)
Khloud A ElSharawy, Thomas A Gerds, Emad A Rakha, Leslie W Dalton
Artificial intelligence grading of breast cancer: a promising method to refine prognostic classification for management precision. Histopathology 79 (2) (2021)
Emad A Rakha, Michael S Toss, Cecily Quinn
Specific cell differentiation in breast cancer: a basis for histological classification. Journal of clinical pathology (2021)
Emad A Rakha, Puay Hoon Tan, Ian Ellis, Cecily Quinn
Adenomyoepithelioma of the breast: a proposal for classification. Histopathology 79 (4) (2021)
Sho Shiino, Graham Ball, Binafsha M Syed, Sasagu Kurozumi, Andrew R Green, Hitoshi Tsuda, Shin Takayama, Akihiko Suto, Emad A Rakha
Prognostic significance of receptor expression discordance between primary and recurrent breast cancers: a meta-analysis. Breast cancer research and treatment (2021)
Ayaka Katayama, Michael S Toss, Matthew Parkin, Takaaki Sano, Tetsunari Oyama, Cecily M Quinn, Ian O Ellis, Emad A Rakha
Nuclear morphology in breast lesions: refining its assessment to improve diagnostic concordance. Histopathology (2021)
Ayat Gamal Lashen, Asmaa Ibrahim, Ayaka Katayama, Graham Ball, Raluca Mihai, Michael Toss, Emad A Rakha
Visual assessment of mitotic figures in breast cancer: a comparative study between light microscopy and whole slide images. Histopathology 79 (6) (2021)
Ayat Gamal Lashen, Michael S Toss, Ayaka Katayama, Rajan Gogna, Nigel P Mongan, Emad A Rakha
Assessment of proliferation in breast cancer: cell cycle or mitosis? An observational study. Histopathology 79 (6) (2021)
Nehal M Atallah, Michael S Toss, Clare Verrill, Manuel Salto-Tellez, David Snead, Emad A Rakha
Potential quality pitfalls of digitalized whole slide image of breast pathology in routine practice. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 35 (7) (2021)
Emad A Rakha, Islam M Miligy, Cecily M Quinn, Elena Provenzano, Abeer M Shaaban, Caterina Marchiò, Michael S Toss, Grace Gallagy, Ciara Murray, Janice Walshe, Ayaka Katayama, Karim Eldib, Nahla Badr, Bruce Tanchel, Rebecca Millican-Slater, Colin Purdie, Dave Purnell, Sarah E Pinder, Ian O Ellis, Andrew H S Lee
Retrospective observational study of HER2 immunohistochemistry in borderline breast cancer patients undergoing neoadjuvant therapy, with an emphasis on Group 2 (HER2/CEP17 ratio ≥2.0, HER2 copy number <4.0 signals/cell) cases. British journal of cancer 124 (11) (2021)
Asmaa Ibrahim, Ayat Lashen, Michael Toss, Raluca Mihai, Emad A Rakha
Assessment of mitotic activity in breast cancer: revisited in the digital pathology era. Journal of clinical pathology (2021)
Khloud A ElSharawy, Michael S Toss, Sara Raafat, Graham Roy Ball, Andrew R Green, Mohammed A Aleskandarany, Leslie W Dalton, Emad A Rakha
Prognostic significance of nucleolar assessment in invasive breast cancer. Histopathology 76 (5) (2020)
Emad A Rakha, Michael S Toss, Sho Shiino, Paul Gamble, Ronnachai Jaroensri, Craig H Mermel, Po-Hsuan Cameron Chen
Current and future applications of artificial intelligence in pathology: a clinical perspective. Journal of clinical pathology 74 (7) (2020)
Emad A Rakha, Cecily M Quinn, Maria Pia Foschini, Monica Muñoz Martin, David J Dabbs, Sunil Lakhani, Zsuzsanna Varga, Sarah E Pinder, Fernando C Schmitt, Jorge Sergio Reis-Filho, Stephen B Fox, Ian O Ellis, Puay-Hoon Tan, Raluca Mihai
Metaplastic carcinomas of the breast without evidence of epithelial differentiation: a diagnostic approach for management. Histopathology 78 (5) (2020)
Islam M Miligy, Michael S Toss, Hazem Khout, Lisa Whisker, Helen C Burrell, Ian O Ellis, Andrew R Green, Douglas Macmillan, Emad A Rakha
Surgical management of ductal carcinoma in situ of the breast: A large retrospective study from a single institution. The breast journal 25 (6) (2019)
Emad A Rakha, Islam M Miligy, Kylie L Gorringe, Michael S Toss, Andrew R Green, Stephen B Fox, Fernando C Schmitt, Puay-Hoon Tan, Gary M K Tse, Sunil Badve, Thomas Decker, Anne Vincent-Salomon, David J Dabbs, Maria P Foschini, Filipa Moreno, Yang Wentao, Felipe C Geyer, Jorge Sergio Reis-Filho, Sarah E Pinder, Sunil R Lakhani, Ian O Ellis
Invasion in breast lesions: the role of the epithelial-stroma barrier. Histopathology 72 (7) (2018)
Emad A Rakha, Mohammed A Aleskandarany, Michael S Toss, Nigel P Mongan, Maysa E ElSayed, Andrew R Green, Ian O Ellis, Les W Dalton
Impact of breast cancer grade discordance on prediction of outcome. Histopathology 73 (6) (2018)
Emad A Rakha, Nuno D M Coimbra, Zsolt Hodi, Enaam Juneinah, Ian O Ellis, Andrew H S Lee
Immunoprofile of metaplastic carcinomas of the breast. Histopathology 70 (6) (2017)

Emad A Rakha.css-eqlu8i{font-size:small;padding-left:4px;} (Emad Rakha)

Publication Activity (10 Years)

Top Topics

Top Venues

Emad A Rakha (Emad Rakha)